Guidant launches improved off-pump system:
This article was originally published in Clinica
Guidant has launched its new Axius Off-Pump System, designed for use in beating heart bypass procedures. The system offers a number of advantages over Guidant's Achieve system, introduced last year. These include a low profile mounting mechanism for positioning target vessels, using the company's Axius XPOSE device to provide access to the rear of the heart. Guidant expects to launch the Axius System in Europe in the near future.
You may also be interested in...
The biopharma industry has struggled to recruit patients into clinical trials that adequately reflect the diverse patient populations they hope to reach with new products. Failure to improve minority subgroup participation now will cost trial sponsors later.
A flurry of US biosimilar launches over the past few months has opened several molecules to true, multi-source competition, with a range of pricing strategies seen from competitors. However, some brands that already face biosimilar competition elsewhere in the world are still poised to enjoy a significant period of exclusivity in the US, such as AbbVie’s Humira.
It is the question that continues to exercise the minds of management boards in the medtech industry even as digital health care tools become increasingly ingrained in commercial R&D and operations – and in patient treatment pathways.